Literature DB >> 17942780

Kidney disease screening program in Japan: history, outcome, and perspectives.

Enyu Imai1, Kunihiro Yamagata, Kunitoshi Iseki, Hiroyasu Iso, Masaru Horio, Hirofumi Mkino, Akira Hishida, Seiichi Matsuo.   

Abstract

In the early 1970s, mandatory kidney disease screening was started with urinalysis in the Japanese health examination program for all workers and school-age children. In 1983, nationwide urinalysis screening in adults aged > or = 40 yr was mandated in the community-based health examination program. Because glomerulonephritis was an endemic disease and the leading cause of end-stage renal disease in Japan until 1997, the urinalysis in the annual health examination program aimed for early detection of glomerulonephritis and early referral of patients to physicians. To the programs, measurement of serum creatinine was added for detection of chronic kidney disease in 1992 for adults aged > or = 40 yr. Kidney disease screening and early intervention brought reduction of progressive glomerulonephritis or an increase in remission. Thus, in children and adults aged < or = 45 yr, the number of patients with end-stage renal disease from glomerulonephritis has declined, and the mean age of patients with new end-stage renal disease has increased significantly. In 1998, the leading cause of end-stage renal disease was shifted from glomerulonephritis to diabetic nephropathy as a result of lifestyle changes in the Japanese population; however, the present comprehensive kidney disease screening in the health examination program for detection of glomerulonephritis must be continued, because even in 2005, 27.3% of newly developed end-stage renal disease was from glomerulonephritis. An additional kidney disease screening program should also be established to target patients with high risk for diabetes, hypertension, and metabolic syndrome, because 42% of newly introduced renal replacement cases were from diabetic nephropathy in 2005.

Entities:  

Mesh:

Year:  2007        PMID: 17942780     DOI: 10.2215/CJN.00980207

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  29 in total

1.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

2.  Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population.

Authors:  Daisuke Uchida; Hiroo Kawarazaki; Yugo Shibagaki; Takashi Yasuda; Naoto Tominaga; Tsuyoshi Watanabe; Koichi Asahi; Kunitoshi Iseki; Chiho Iseki; Kazuhiko Tsuruya; Kunihiro Yamagata; Toshiki Moriyama; Ichiei Narita; Shoichi Fujimoto; Tsuneo Konta; Masahide Kondo; Masato Kasahara; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2014-08-24       Impact factor: 2.801

3.  Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries.

Authors:  Yusuke Tsukamoto; HaiYan Wang; Gavin Becker; Hung-Chun Chen; Dae-Suk Han; David Harris; Enyu Imai; Vivekanand Jha; Philip K T Li; Evan J C Lee; Seiichi Matsuo; Yasuhiko Tomino; Kriang Tungsanga; Kunihiro Yamagata; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2009-03-14       Impact factor: 2.801

Review 4.  Screening Urinalysis in Detection of Chronic Kidney Disease in Children.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2018-05-23       Impact factor: 1.967

5.  Detection of urinary abnormalities in a community from northern Italy based on the World Kidney Day screening program.

Authors:  F Fabbian; P L Bedani; E Rizzioli; C Molino; M Pala; A De Giorgi; C Longhini; F Portaluppi
Journal:  Int Urol Nephrol       Date:  2010-11-04       Impact factor: 2.370

6.  Combined application of eGFR and albuminuria for the precise diagnosis of stage 2 and 3a CKD in the elderly.

Authors:  Conghui Liu; Haiping Chen; Cuiyun Liu; Chen Fu; Hui Zhang; Huayu Yang; Peng Wang; Fan Wang; Shujun Chen; Qing Ma
Journal:  J Nephrol       Date:  2014-03-08       Impact factor: 3.902

Review 7.  Role of chronic kidney disease in cardiovascular disease: are we different from others?

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2011-04-05       Impact factor: 2.801

8.  Population-based screening for CKD.

Authors:  Neil R Powe; L Ebony Boulware
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

9.  The See Kidney Disease Targeted Screening Program for CKD.

Authors:  Lauren E Galbraith; Paul E Ronksley; Lianne J Barnieh; Joanne Kappel; Braden J Manns; Susan M Samuel; Min Jun; Rob Weaver; Nadine Valk; Brenda R Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

10.  Screening for albuminuria identifies individuals at increased renal risk.

Authors:  Marije van der Velde; Nynke Halbesma; Frank T de Charro; Stephan J L Bakker; Dick de Zeeuw; Paul E de Jong; Ronald T Gansevoort
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.